Anti-wrinkle effect of cosmetic serum for eye
Not Applicable
- Conditions
- Healthy adult female
- Registration Number
- JPRN-UMIN000043894
- Lead Sponsor
- Japan Clinical Trial Association
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- Female
- Target Recruitment
- 14
Inclusion Criteria
Not provided
Exclusion Criteria
1. Subjects with cosmetic allergies 2. Subjects who are pregnant or lactating 3. Subjects with inflamed or scraped skin on face 4. Subjects who are judged as unsuitable for the study by the investigator for the other reason
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method wrinkle grade
- Secondary Outcome Measures
Name Time Method subjective evaluation
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways does the anti-wrinkle eye serum in JPRN-UMIN000043894 target for periorbital wrinkle reduction?
How does the clinical efficacy of JPRN-UMIN000043894's eye serum compare to hyaluronic acid-based treatments in reducing periorbital wrinkles?
Are there specific biomarkers in healthy adult females that predict response to anti-wrinkle serums like JPRN-UMIN000043894's formulation?
What are the potential adverse events associated with JPRN-UMIN000043894's anti-wrinkle eye serum and how are they managed?
What synergistic effects are observed when combining JPRN-UMIN000043894's eye serum with retinol or vitamin C in cosmetic dermatology?